SCHEMBL12414355

SCHEMBL12414355

CONC(=O)c1ccc(OC(=O)ON2C(=O)CCC2=O)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
GLA P06280 1/20 0.38
POLB P06746 1/20 0.37
MMP13 P45452 1/20 0.36
PLK1 P53350 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
KMT2A Q03164 4/20 0.35
MEN1 O00255 2/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAPT P10636 1/20 0.35
THRB P10828 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
RECQL P46063 1/20 0.35
BLM P54132 1/20 0.35
ATM Q13315 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12421900 0.86 HPGD (0.50) GLAMMP13PLK1HPGDKMT2A
SCHEMBL277428 0.83 SMN1; SMN2 (0.41) GLAPOLBHPGDKMT2AMEN1
SCHEMBL14675487 0.83 HPGD (0.46) GLAMMP13PLK1ALDH1A1HPGD
SCHEMBL12410677 0.82 HPGD (0.48) POLBALDH1A1HPGDKMT2AMAPT
SCHEMBL2607958 0.81 GLA (0.46) GLAPOLBHPGDKMT2AMAPT
SCHEMBL7109646 0.81 PARP10 (0.46) CA1CA2GLAALDH1A1KMT2A
SCHEMBL12422042 0.81 POLB (0.50) CA1CA2GLAPOLBALDH1A1
SCHEMBL14755842 0.81 SRD5A1 (0.47) GLAPOLBALDH1A1HPGDKMT2A
SCHEMBL12414298 0.79 LMNA (0.36) GLAPOLBALDH1A1HPGDKMT2A
SCHEMBL17462699 0.79 MMP13 (0.49) CA1CA2GLAPOLBMMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9682153-B2 Polymer conjugates of therapeutic peptides NEKTAR THERAPEUTICS (US) 2017-06-20 US disclosed
US-20160022828-A1 POLYMER CONJUGATES OF THERAPEUTIC PEPTIDES NEKTAR THERAPEUTICS 2016-01-28 US disclosed
US-20110166063-A1 POLYMER CONJUGATES OF THERAPEUTIC PEPTIDES NEKTAR THERAPEUTICS (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160022828-A1 POLYMER CONJUGATES OF THERAPEUTIC PEPTIDES NGLY1, CD44, IAPP CA1 905/4885CA2 3392/4885GLA 2752/4885
US-20110166063-A1 POLYMER CONJUGATES OF THERAPEUTIC PEPTIDES NGLY1, CD44, IAPP CA1 905/4885CA2 3392/4885GLA 2752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.